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The recent identification of multiple dominant mutations in the gene encoding b-catenin in
both humans and mice has enabled exploration of the molecular and cellular basis of b-
catenin function in cognitive impairment. In humans, b-catenin mutations that cause a
spectrum of neurodevelopmental disorders have been identified. We identified de novo b-
catenin mutations in patients with intellectual disability, carefully characterized their
phenotypes, and were able to define a recognizable intellectual disability syndrome. In
parallel, characterization of a chemically mutagenized mouse line that displays features
similar to those of human patients with b-catenin mutations enabled us to investigate the
consequences of b-catenin dysfunction through development and into adulthood. The
mouse mutant, designated batface (Bfc), carries a Thr653Lys substitution in the C-terminal
armadillo repeat of b-catenin and displayed a reduced affinity for membrane-associated
cadherins. In association with this decreased cadherin interaction, we found that the
mutation results in decreased intrahemispheric connections, with deficits in dendritic
branching, long-term potentiation, and cognitive function. Our study provides in vivo
evidence that dominant mutations in b-catenin underlie losses in its adhesion-related
functions, which leads to severe consequences, including intellectual disability, childhood
hypotonia, progressive spasticity of lower limbs, and abnormal craniofacial features in
adults.
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The recent identification of multiple dominant mutations in the gene encoding β-catenin in both humans and 
mice has enabled exploration of the molecular and cellular basis of β-catenin function in cognitive impair-
ment. In humans, β-catenin mutations that cause a spectrum of neurodevelopmental disorders have been 
identified. We identified de novo β-catenin mutations in patients with intellectual disability, carefully charac-
terized their phenotypes, and were able to define a recognizable intellectual disability syndrome. In parallel, 
characterization of a chemically mutagenized mouse line that displays features similar to those of human 
patients with β-catenin mutations enabled us to investigate the consequences of β-catenin dysfunction through 
development and into adulthood. The mouse mutant, designated batface (Bfc), carries a Thr653Lys substitu-
tion in the C-terminal armadillo repeat of β-catenin and displayed a reduced affinity for membrane-associat-
ed cadherins. In association with this decreased cadherin interaction, we found that the mutation results in 
decreased intrahemispheric connections, with deficits in dendritic branching, long-term potentiation, and 
cognitive function. Our study provides in vivo evidence that dominant mutations in β-catenin underlie losses 
in its adhesion-related functions, which leads to severe consequences, including intellectual disability, child-
hood hypotonia, progressive spasticity of lower limbs, and abnormal craniofacial features in adults.
Introduction
β-Catenin (CTNNB1) is a highly conserved protein that imple-
ments key cellular functions by interacting with cell-adhesion 
proteins, signaling molecules, and transcription factors (1). The 
characteristic structural feature of the β-catenin protein, its 12 
central armadillo repeats, forms a long positively charged groove 
facilitating interaction with multiple protein partners. This cen-
tral motif is flanked by the N terminus, crucial in mediating degra-
dation of the protein, and the C terminus, containing the Helix-C 
motif (2), which enables switching between the protein’s dual 
roles in cell adhesion and proliferation. Loss-of-function studies 
in mammals have implicated β-catenin in embryonic develop-
ment, while gain-of-function studies have demonstrated its con-
tribution to various forms of human cancers (reviewed in ref. 3). 
Functional investigation has focused on the role of β-catenin in 
canonical WNT signaling. β-Catenin interacts with transcrip-
tional coactivators to mediate WNT’s transcriptional activa-
tion, which orchestrates growth and patterning in the develop-
ing embryo, and, when constitutively upregulated, dysregulates 
growth connected to cancer and metastasis.
In addition to its role in the WNT-signaling pathway, β-catenin 
serves as a major intracellular anchor for membrane cadherins, 
a family of cell-adhesion molecules that modulate synaptic con-
nectivity (4). The intracellular domains of cadherins can estab-
lish interactions across the whole central 12-armadillo motifs of 
β-catenin. This interaction integrates multiple, independent pro-
cesses (5), such as maintaining cell adhesion and regulating cell 
migration and neurite outgrowth (6, 7). One model proposes that 
β-catenin participates in synaptic remodeling through regulating 
these interactions (8). Because synaptic changes are key cellular 
processes underlying memory (9), regulated stability of the cad-
herin-catenin complex could be a cellular mediator of memory. In 
fact, using a conditional null mutant, β-catenin has been shown 
to play a significant role in long-term memory consolidation (10).
Through high-throughput genomics approaches, evidence impli-
cating β-catenin in human cognitive disorders has come to light 
recently (11, 12). Large-scale sequencing efforts have found that 
rare de novo point mutations in CTNNB1 represent a major contri-
bution to intellectual disability (ID) (13) and to autism spectrum 
disorders (ASD) (12). These studies have uncovered 4 potential 
causative mutations in CTNNB1; 3 were loss-of-function mutations 
in patients with ID (p.Ser425Thrfs*11, p.Arg515* and p.Gln309*) 
(13) and one was a missense mutation in a patient with ASD 
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J Clin Invest. 2014;124(4):1468–1482. doi:10.1172/JCI70372.
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 4   April 2014 1469
(p.Thr551Met) (12). Following our previous ID study, we present 
here a complete characterization of the phenotypic characteristics of 
the patients. In addition, we lately identified another individual with 
a de novo CTNNB1 mutation (c.705dup; p.Gly236Argfs*35) and 
both mutation and clinical description of this case are presented 
here for the first time. In parallel with these findings, we have iden-
tified a mouse model, batface (Bfc), with an N-ethyl-N-nitrosourea–
induced (ENU-induced) missense mutation in β-catenin. The bat-
face mutant has specific morphological, behavioral, molecular and 
physiological anomalies that remarkably parallel the homologous 
human conditions. Here, we have collected and analyzed phenotypic 
data from both human patients and the mouse model to provide a 
comprehensive picture of the role of β-catenin in the onset and pro-
gression of these severe neurodevelopmental conditions.
Results
Individuals with de novo mutations in β-catenin express a spectrum of 
clinical features associated with abnormal behavior and neurodevelopment. 
Based on recurrent recent findings in a number of whole genome 
sequencing studies, we were prompted to investigate the clinical 
Figure 1
Craniofacial anomalies associated with β-catenin mutations in humans and mice. (A) Patients 1 (at the age of 4 years), 2 (at the age of 29 years), 
3 (at the age of 24 years and 51 years), and 4 (at the age of 14 years) with de novo mutations in CTNNB1 (p.Gln309*, p.Ser425Thrfs*11, 
p.Arg515*, and p.Gly236Argfs*35, respectively). Note the overlap in craniofacial features including microcephaly, a full tip of the nose, and thin 
upper lip. Written informed consent was obtained to use the medical data and photographs from legal representatives of the 4 patients. (B) Broad-
face phenotype characteristic of all Bfc/+ adults compared with a WT littermate control. (C) Broad-face phenotype in Bfc/+ is associated with a 
short snout and broad skull as determined by x-ray scanner. (D) Sequence analysis of Ctnnb1 in Bfc/+ and WT DNA revealing a C-to-A transi-
tion at nucleotide position 2245 in the Bfc mutant. This missense mutation results in a Thr653Lys amino acid substitution. (E) Protein sequence 
alignment of CTNNB1 in human, mouse, and other vertebrate species. The Thr653Lys substitution lies within the highly conserved 12th armadillo 
repeat of the protein. (F) Representative structure of CTNNB1 showing N- and C-terminal domains and the Arm12 repeats. The approximate 
positions of 5 human (Thr551Met from ref. 12) mutations and the Thr653Lys mouse mutation are indicated.
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features associated with human de novo β-catenin mutations. We 
performed detailed phenotype studies in the 4 individuals with ID 
and concluded that they displayed highly similar and specific fea-
tures that led us to define what we believe to be a novel recognizable 
syndrome comprising mild to severe ID, ASD childhood hypotonia 
with progressive spastic diplegia, (primary) microcephaly, and sig-
nificant additional craniofacial and brain abnormalities, including 
corpus callosum hypoplasia (Figure 1A). Additional clinical descrip-
tions are included in the Supplemental Clinical Description (sup-
plemental material available online with this article; doi:10.1172/
JCI70372DS1). As all ID mutations identified (Figure 1F) predict 
loss-of-function, resulting in significant protein truncation, we 
investigated whether the mutant mRNAs would undergo nonsense-
mediated decay. This was observed in 2 of the 4 individuals using 
allele-specific cDNA amplification of EBV-treated patient lympho-
cytes in the presence or absence of cycloheximide (Supplemental 
Figure 1). These results suggested that CTNNB1 haploinsufficiency 
is responsible for the craniofacial and ID phenotypes in the patients.
An ENU mutagenesis screen reveals a β-catenin mouse mutant. In a parallel 
study, we identified a single animal within a G1 population of ENU-
mutagenized animals (14) showing a dominant craniofacial phe-
notype with characteristic broad facial features (Figure 1, B and C). 
Named batface (Bfc, MGI:2656734) because of its distinct craniofacial 
dysmorphology, the phenotype was inherited in a dominant fashion 
while intercrosses revealed that the mutation was homozygous lethal 
with lethality occurring at mid to late gestation (15). We mapped the 
dominant craniofacial phenotype at low resolution using 13 affected 
animals. Finding a single region of linkage on distal chromosome 9, 
we used additional markers and animals and refined the nonre-
combinant region to 0.56 Mb between 120.92 Mb and 121.48 Mb. 
As only 2 transcripts mapped to the region, we sequenced all coding 
exons and identified a single missense mutation, a C-to-A transition, 
in exon 13 of the β-catenin gene (Ctnnb1; Figure 1D). The mutation 
results in a Thr653Lys substitution in the highly conserved 12th 
armadillo repeat at the C-terminal end of the protein (Figure 1E). 
Initial functional investigations in midgestational embryos sug-
gested that the Bfc mutation acts through a gain-of-function in the 
WNT-mediated transcriptional pathway (15). However, unlike other 
gain- or loss-of-function mutations in β-catenin, this was the first 
example of a mouse mutation, to our knowledge, to reference a cra-
niofacial dysmorphology in heterozygous adults. Significant cranial 
differences occur in Ctnnb1Bfc/+ (Bfc/+) mice compared with littermate 
controls, including a shortened nasal length and an augmentation 
of the interorbital distance and of the bregma to bony ridge length 
(Figure 1C and Supplemental Figure 2). In considering the similar 
overt features of CTNNB1 mutations in humans and Bfc/+ mice, we 
were prompted to assess the nature of the Bfc mutation in mice. So 
we carried out a number of protein function studies to investigate 
whether any of the prominent roles of CTNNB1 could be compro-
mised in Bfc/+ mice.
The Bfc mutation disrupts the cadherin–β-catenin interaction. To deter-
mine the nature of the Bfc mutation, we first examined whether pro-
tein levels were affected (Supplemental Figure 3). As no differences 
were identified in Western blots, we investigated whether the muta-
tion could affect the ability of β-catenin to interact with any of its 
known interacting partners. Specifically, the role of the C-terminal 
armadillo repeat has been well documented in anchoring membrane-
bound cadherins to the intracellular cytoskeleton (5, 16). Moreover, 
the tyrosine residue adjacent to the Bfc mutation (Tyr654) is crucial 
in maintaining this interaction. Docking of an N-terminal α-helix 
in cadherin within a groove formed by armadillo repeats 11 to 12 
of β-catenin can be reduced by 85% when Tyr654 is phosphorylated 
(17). To investigate whether Thr653Lys would similarly disrupt the 
docking of the N-terminal cadherin helix, we immunoprecipitated 
native protein from WT and Bfc/+ adult hippocampal whole-cell 
lysates. Strikingly, we found that the cadherin-catenin interaction 
was significantly reduced, by 46% (P < 0.01; t test) in Bfc/+ hippocam-
pus (Figure 2, A and B). This reduced affinity of mutant β-catenin for 
cadherin was subsequently confirmed in immunoprecipitates from 
HEK293 cells transiently transfected with N-cadherin and β-catenin 
mammalian expression constructs (Figure 2, C and D). Using avail-
able models of β-catenin and E-cadherin structure, we investigated 
whether a Thr653Lys substitution had the potential to disrupt inter-
actions between these 2 proteins (Figure 2, E–H, and Supplemental 
Figure 4). From the superposition of the 3D models of mutant, WT, 
and Tyr654-p β-catenin (Figure 2H), Tyr654-p has been observed to 
break the hydrogen bond with Asp665 in cadherin (5). In investigat-
ing the interacting helices of β-catenin and cadherin, it would appear 
that the predicted 3D model of mutant β-catenin shows a disruption 
of the interaction with cadherin, causing a steric bulge, similar in 
effect to the Tyr654-p.
Morphological analysis reveals brain abnormalities in Bfc/+ mice. We pro-
ceeded to characterize Bfc at neuroanatomical and behavioral levels. 
Using MRI, we found a number of major abnormalities in mutants. 
The anteroposterior axis was significantly shortened, whereas the 
dorsoventral and medial-lateral axes were enlarged (Figure 3, A and B). 
In contrast to what was found in mice overexpressing β-catenin (18), 
gyrification of the cerebral cortex was not observed. However, gray 
matter and total brain volumes were significantly larger in Bfc/+ 
(P < 0.05; 1-way ANOVA, Supplemental Figure 5A). When normal-
ized to brain volume, however, the relative gray matter and white 
matter content in Bfc/+ was not statistically different from that of 
controls (Supplemental Figure 5B). Alterations in the absolute and 
relative volume of multiple anatomical brain structures were also 
found (Supplemental Figure 6). The thalamus, striatum, and glo-
bus pallidus were slightly, but significantly, larger in Bfc/+. However, 
mutants showed substantially reduced cerebellar and olfactory bulb 
volumes compared with WT. In addition to these general morpho-
logical features, the corpus callosum appeared to be severely under-
developed in 3 Bfc/+ individuals, lacking any interhemispheric exten-
sions (Figure 3, C–E). This was reminiscent of the human case with 
callosal hypoplasia described above. No evidence of major corpus 
callosum alterations was observed in the remaining Bfc/+ brains or 
in the control group. Reductions in olfactory bulb, cerebellum size, 
and abnormal corpus callosum found with MRI were confirmed in 
histopathological sections of mouse brain (Supplemental Figure 7).
Bfc mutant mice show deficits in sensorimotor gating, motor function, and 
vocalization complexity. We studied specific behaviors in mice that 
related to deficits evident in the human ID cases, including motor 
dysfunction, cognitive disabilities, and vocalization deficiencies. 
Acoustic startle response (ASR) (Figure 4A) and prepulse inhibition 
(PPI) (Figure 4B) of ASR reflect the ability of an animal to respond 
to and integrate sensory information (19). Bfc/+ mice showed con-
sistent and significant PPI deficits, whereas ASR was normal. Motor 
deficits were present but were more subtle. On a typical rotarod 
test, Bfc/+ mice showed no significant deficit (data not shown). 
However, when tested with a more challenging test incorporat-
ing 6 consecutive accelerating stages in a single session, Bfc/+ mice 
showed a significantly shorter latency period before falling from 
the rod, and these differences were maintained when trials were 
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repeated over 3 days (Figure 4C). Mice emit ultrasonic vocalizations 
under certain conditions, such as maternal separation. We tested 
ultrasonic vocalizations at postnatal day 6 by separating pups 
from their mothers for 5 minutes. We observed a significant reduc-
tion in the total number of vocalizations in mutants (Figure 4D). 
The mean duration of each vocalization was slightly shorter, 
although not significant. Finally, mutant pups produced more calls 
characterized by a single component (Figure 4, E and F), suggesting 
that they have developed a less complex vocalization system.
Learning and memory deficits in Bfc mutants. One of the defining char-
acteristics of individuals with ID is the cognitive deficit. To investi-
gate cognitive abilities in Bfc/+ mice, we used 2 hippocampus-related 
tests, the water maze (WM) test (20) and the fear conditioning test 
(21). In the WM, a test for spatial learning, we trained mice for 4 days 
with a visible platform to trigger hippocampus-independent naviga-
tion followed by training with a hidden platform to measure hip-
pocampus-dependent learning. We observed no differences in the 
latency period before finding the visible platform. However, while 
control animals improved their performance with the hidden plat-
form, Bfc/+ mice did not improve (Figure 5A). Bfc/+ mice showed 
a consistent delay at probe trials at the end of each daily session 
(Figure 5B), although their swimming ability was normal (Figure 5, 
C and D), confirming a deficit in hippocampus-dependent perfor-
mance. When Bfc/+ mice were tested in a standard fear condition-
ing protocol for contextual memory, their freezing behavior during 
reexposure to the context was significantly lower than that of litter-
mate controls (Figure 5C), indicating that mutants have a reduced 
capacity to recall the previous shock exposure.
Figure 2
The Thr653Lys mutation disrupts the murine 
β-catenin–cadherin complex. (A) Western 
blot of adult hippocampal whole-cell lysates 
immunoprecipitated with anti–N-cadherin. 
Typical N-cadherin and β-catenin immu-
noreactive bands are shown. An Ig control 
lysate IP using normal rabbit IgG is included. 
Black lines indicate noncontiguous regions. 
(B) β-catenin immunoreactivity was nor-
malized to immunoprecipitated N-cadherin, 
revealing a 46% reduced interaction in mutant 
hippocampal lysates (n = 7, **P < 0.01). 
(C) Western blot of lysates from HEK293 
cells transfected with N-cadherin–EGFP 
and β-catenin–V5/His and immunoprecipi-
tated with anti-EGFP. Control IPs were car-
ried out from cells transfected with only the 
WT β-catenin–V5/His plasmid. White lines 
indicate noncontiguous regions. (D) Recom-
binant β-catenin immunoreactivity was nor-
malized to immunoprecipitated recombinant 
N-cadherin, confirming reduced interaction 
(40% reduction, n = 3, *P = 0.03). (E) Close-
up view of the interacting residues in the WT 
complex. β-catenin is shown in green. T653 
and Y654 (blue sticks) in β-catenin are both 
located on the surface of the ARM12 helix 3. 
E-cadherin (red) helix is shown with contact-
ing residues D665 and L661. D665 of E-cad-
herin forms the hydrogen bond with Y654. 
(F) Description is the same as in E; how-
ever, the phosphorylated tyrosine (Y654-p) 
residue is shown. (G) Close-up view of inter-
acting residues in the mutant form (T653K). 
K653 (blue sticks) is shown in the IntFOLD2 
(35, 36) model of the β-catenin armadillo 
domain (yellow). The mutant residue extends 
to contact the E-cadherin backbone (red). 
(H) 3D-modeled β-catenin with the K653 
mutation superimposed on the crystal struc-
ture of β-catenin, showing K653 with Y654-p 
vis-a-vis the E-cadherin–interacting resi-
dues: D665, L661, and I657.
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Timing and decision making is distorted in Bfc mutants. To test timing 
in cognitive processing, we used a basic “peak procedure” paradigm 
(22) in which mice were trained to collect a reward at a particular time 
interval after a light event (Figure 6A). For trials in which rewards 
were given, responses increased significantly during the expected 
time interval in WT mice, but not in Bfc/+ mutants (Figure 6B). 
Moreover, in probe trials where no reward was given, responses of 
Bfc/+ mice during the critical time window were significantly lower 
than littermate controls (Figure 6B). Using an automated home-
cage version of the peak procedure protocol (23), we recorded the 
animals’ performance through their regular sleep-wake cycle for 
several days. This more accurate analysis of temporal responses 
confirmed the learning deficit. We found no difference in the peak 
distribution between the first and last day of training in Bfc/+ mice, 
while controls reduced their peak time and the spread of their tem-
poral responses (Figure 6, C and D). We further investigated tempo-
ral behavior by identifying the “start” and “stop” indices from the 
cumulative distribution of nose pokes (Supplemental Figure 8) to 
assess anticipatory and perseverative behaviors, respectively. Inter-
estingly, during training, Bfc/+ mice did not moderate their response 
times, indicating a lack of temporal coordination and perseverative 
behavior (Figure 6E). Furthermore, we tested whether mice were 
able to discriminate short- versus long-interval light signals by nose 
poking in the appropriate location. This test (24) assesses whether 
the animal has an accurate endogenous (subjective estimation of 
the signal duration) and exogenous (ratio between short and long 
signals) timing representation. Accuracy and precision were signifi-
cantly worse in Bfc/+ mice (Supplemental Figure 9, A and B) during 
the dark phase of the 12-hour light/12 hour-dark cycle, when mice 
are most active. This was confirmed by analysis of error rates (i.e., 
nose pokes in the inappropriate location). While the error rate in 
control mice increased only during the light phase, Bfc/+ mice had a 
constant high error rate (Figure 6, F and G).
Synaptic morphology and functionality are altered in Bfc mice. We inves-
tigated whether behavioral deficits might be associated with deficits 
in neuronal architecture and functional connectivity in Bfc/+ brains. 
We first looked at neurite growth and arborization in primary neu-
rons cultured from embryonic hippocampus. We found that the 
morphology of both heterozygous and homozygous Bfc neurons 
was different after only 1 day in culture (Supplemental Figure 10A). 
In particular, the length and number of neurites were significantly 
increased in Bfc mutants (Supplemental Figure 10B). However, after 
8 days in culture, the majority of homozygous neurons lost their 
integrity, while the extent of dendritic branching in Bfc/+ neurons 
was dramatically lower than in controls (Figure 7, A and B). More-
over, the depolarizing effect of high K+ on dendritic arborization 
and neurite length was inhibited in Bfc/+ neurons (Supplemental 
Figure 11). As the identified human de novo β-catenin mutations 
would generate mRNAs undergoing non–sense- mediated decay and 
consequently result in CTNNB1 haploinsufficiency, we studied the 
effect of reduced β-catenin expression on neuronal development. 
To this aim, we transfected primary neuronal cultures obtained 
from WT mice with an siRNA against CTNNB1. Transfection of 
this siRNA decreased β-catenin expression by 54% in WT cultures 
(Figure 7D), thus closely mimicking the reduction expected in 
patients bearing β-catenin mutations. Compatible with the reduc-
tion in neurite extension observed in neuronal cultures from Bfc 
mutant mice (Figure 7B), siRNA-mediated β-catenin knockdown in 
WT cultures produced a significant decrease in neurite length and 
in the number of processes compared with cultures transfected with 
a control siRNA (Figure 7D), indicating the pivotal role of β-catenin 
in shaping neuronal architecture.
Figure 3
MRI scans of Bfc/+ mice reveal major brain abnormalities. MRI scans 
of Bfc/+ mice highlighted an altered cranial shape with a larger left-
right axis and a shorter longitudinal extension compared with controls. 
The effect was apparent in horizontal (A) and sagital (B) views of the 
brain. The olfactory bulbs and cerebellum appeared to be significantly 
smaller in Bfc/+ individuals compared with control littermates. In 3 out 
of 10 Bfc/+ subjects, the corpus callosum appeared to be severely 
underdeveloped, lacking any interhemispheric extension. This was 
apparent in anatomical T2-weighted images (C) as well as in diffusion-
weighted scans (D and E). Diffusion tensor images (DTI) modulated by 
FA (D) and DTI tractography corroborated the lack of interhemispheric 
connection of the corpus callosum in all of the 3 subjects, showing 
abnormal callosal anatomy in anatomical MRI images (C, D, and E 
show data from representative Bfc/+ and control subjects). Normal 
interhemispheric tracts were observed in all the control subject images. 
Cereb, cerebellum; Cpu, caudate putamen; Olf Bulb, olfactory bulbs; 
Hippoc, hippocampus; Hypot, hypothalamus.
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To determine whether structural changes could lead to func-
tional differences at the scale of neuronal networks, we cultured 
hippocampal neurons on high-density multi-electrode arrays (MEA). 
The electrodes allowed us to record extracellular action potentials 
from up to 4,096 electrodes on a 2.67 mm2 area. To identify function-
al differences among cultured networks, cell cultures were seeded at 
low density (Figure 7E) to obtain a sparse network coupled with the 
large-scale electrode array, thus achieving a high percentage of elec-
trodes recording single units. Under these conditions, results from 
spike sorting showed that approximately 84% of selected electrodes 
recorded single units (Supplemental Table 1). Electrophysiological 
activity was recorded in the spontaneous condition and in the pres-
ence of bicuculline (BIC) to disinhibit the network. The cumulative 
distributions of network-wide activity parameters, i.e., mean firing 
rate (MFR) and mean bursting rate (MBR), are right shifted and are 
indicative of a higher excitability of networks from Bfc/+ mice. Dif-
ferences in the analysis of the mean burst duration (MBD) are less 
evident. This higher network excitability was also observed when we 
analyzed data by separating the spontaneous from the disinhibited 
data sets (data not shown). Further, the synaptic strength was evalu-
ated based on outcomes from the functional connectivity estimation 
among a large number of single units in the network. Based on the 
analysis of the length of the strongest links within cultured networks 
(Figure 7I), we observed that Bfc/+ neuronal networks maintain 
longer link lengths compared with controls. The link strength and 
degree of connectivity were observed to be lower in Bfc/+ networks 
(data not shown). This indicates that the functional connectivity in 
hippocampal neuronal networks formed from Bfc/+ heterozygous 
mice, especially at the local circuitry level, is less efficient.
We determined whether functional differences in cultured neuronal 
networks might be related to ultrastructural anomalies in brains of 
adult Bfc/+ mice. We performed electron microscopic analysis of 
cortical and CA1 hippocampal regions from adult brain sections. In 
heterozygotes,we observed a lower density of docked synaptic vesicles 
(SV) in cortex and CA1 (Figure 8, A and B). Lower SV density could 
thus indicate a lower release probability at Bfc/+ synapses and hence 
a lower synaptic strength. To investigate this further, we recorded 
field-evoked postsynaptic potentials (fEPSPs) in the CA1 region of 
hippocampal slices, evoked by stimulating the Schaffer collateral path-
way (Figure 8C). The slope of fEPSP in Bfc/+ was not significantly dif-
ferent from that in controls (Figure 8D, 2-way ANOVA, P > 0.05), nor 
was there a difference in the observed paired-pulse ratio (Figure 8E, 
2-way ANOVA, P > 0.05). We then investigated the effect of the muta-
tion on synaptic plasticity and found that long-term potentiation 
(LTP) induced by either tetanic (Figure 8F) or θ-burst (Figure 8G) 
stimulation was significantly reduced in slices from Bfc/+ animals.
Discussion
In this study, we have clearly shown that β-catenin plays key roles 
affecting brain function, morphology, and craniofacial features 
Figure 4
Behavioral phenotypes of Bfc/+ adult mice. (A) ASR in Bfc/+ (n = 10) mice is unaffected compared with that of controls (n = 10). (B) Reduction in 
PPI is extremely robust, with significant reductions seen in Bfc/+ mice. (C) Rotarod performance over 3 daily sessions is lower in Bfc/+ (n = 10) 
mice compared with controls (n = 10), although their performance has improved by the third day. (D) Ultrasonic vocalizations are disrupted in 
Bfc/+ (n = 10) mice compared with littermate controls (n = 10), with reductions in the total number of calls upon separation and in the average 
call duration. (E) Call complexity is also lower in mutants. with a significantly lower number of elements per call. (F) Representative ultrasonic 
vocalizations for WT mice and Bfc/+ littermates. *P < 0.05, **P < 0.01, Student’s t test.
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in both mouse and human. This underlines the recent proposal 
that the β-catenin protein–interacting network is important in 
abnormal neurodevelopmental etiology (12, 25). We were able 
to define a clinically recognizable syndrome in humans with a 
distinctive phenotype, including ID, ASD, microcephaly, and 
childhood hypotonia with progressive spastic diplegia, associ-
ated with de novo mutations in CTNNB1. The individual with 
the p.Thr551Met mutation in CTNNB1 who was presented in 
the ASD study (12) may also fit in this clinical spectrum, since 
this person was described to have, in addition to ASD, a non-
verbal IQ in the range of moderate ID (NVIQ 58). No further 
clinical data were provided, however. Interestingly, our results 
are also in agreement with the finding that Wnt and β-catenin 
proteins are decreased in frontal cortex in post-mortem brain 
tissue of individuals with ASD. These deficits were associated 
with abnormal dendritic branching and reduced cell body size 
of astrocytes (26). Furthermore, the parallels in the phenotypic 
features with the mouse model, batface, strongly suggest shared 
common pathological mechanisms in morphologic and neuro-
developmental processes in human and mouse. Consequently, 
we have taken advantage of the batface mouse model to fur-
ther explore the role of β-catenin in CNS functions and have 
Figure 5
A number of parameters of learning and memory are deficient in Bfc/+ mice. WM test showing mean latencies to reach the escape platform are 
plotted for daily sessions over 8 training days (A) and for probes (B) in Bfc/+ and littermate controls (n = 10). Visible platform (VP) and hidden 
platform (HP) conditions are marked along the training. Mean distances for regular training (C) and probe (D) trials are plotted. In the fear con-
ditioning test, freezing time during habituation and training (E) and exposure to the context and cue conditions (F) are presented for Bfc/+ mice 
(n = 8) and littermate controls (n = 8). *P < 0.05, ***P < 0.001; Student’s t test.
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Figure 6
Bfc/+ mice show deficits in temporal cognition. (A) The peak procedure task. Probes differ from normal trials, as the light stimulus is not followed by 
any reward. (B) Mean nose pokes for the rewarded time windows (RTWs) within each session are presented for normal trials over 8 consecutive days 
and all probe trials. Bfc/+ mice (n = 12) do not increase nose poking within the RTW as +/+ mice do (n = 12). (C) Timing responses are collected in 
a home-cage apparatus using separate mouse cohorts (n = 6). Peak time and width (spread) decrease significantly between the first and last day 
in +/+, but not in Bfc/+ mice. *P < 0.05; **P < 0.01. (D) Peak distribution for the first (red) and last (blue) days for representative +/+ and Bfc/+ mice. 
(E) Start and stop times test anticipatory and perseverative behaviors. WT mice show a progressive optimization (increasing the start time and 
decreasing the stop time) in their responses, corresponding with reward delivery time. Interestingly, Bfc/+ mice do not modify stop time responses, 
indicating a perseverative response within trials. (F) Timing is assessed for 2 intervals (short vs. long), and only correct responses are rewarded. 
Error rates are calculated and plotted in 3-hour bins; the blue bar represents the dark phase of the 12-hour light/12-hour dark cycle. A comparison of 
behaviors during the dark (active) and light (inactive) phases is shown for Bfc/+ and +/+ mice (G). No phase differences in behavior are evident in 
Bfc/+ mice, while the error rate significantly increases in WT animals in the light phase.
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identified specific molecular and synaptic deficits that could 
be responsible for the range of developmental, behavioral, and 
cognitive deficits seen.
The batface mutant expresses a unique phenotype that is a 
combined consequence not only of a gain in WNT-related func-
tion (15), but also, as we show here, a dominant-negative effect on 
adhesion-related function. For what we believe is the first time, this 
allows investigation of in vivo consequences of mutant β-catenin 
function in adult heterozygotes. Although specific embryonic 
brain deficits have been noted in conditional null mutants includ-
ing, in some cases, abnormalities in development of the corpus 
callosum (27–29), none of these studies have focused on postnatal 
mutant phenotypes, nor have they noted dysmorphisms or behav-
ioral deficits in heterozygotes. Although the lack of deficits in 
heterozygous loss-of-function mouse mutations does not seem 
consistent with the severe phenotype associated with β-catenin 
loss-of-function in humans, Huelsken et al. (30) suggested that 
plakoglobin can assume β-catenin’s adhesive role in its absence. 
This might not only explain the apparent differences in loss-of-
function mutations in mouse and humans, but may also account 
for the unique nature of the Bfc mutation. Given the continued 
ability of mutant β-catenin to interact with the cytoskeleton and 
with other protein partners, the presence of the Bfc mutant protein 
is likely to inhibit the ability of plakoglobin to assume its compen-
satory adhesive role in heterozygous animals.
As a testament to the complex network of CTNNB1 and its 
interacting partners, the severity of the batface mutation and its 
pleiotropy can vary as a function of genetic background. On any 
congenic background investigated in this or in previous studies 
(15), the viability of heterozygous embryos and fertility of adults 
are compromised, although craniofacial dysmorphisms and some 
behavioral traits are robust and found to be insensitive to back-
ground (data not shown). To produce sufficient cohorts of ani-
mals for this study, we chose to use animals of mixed genetic back-
ground. This did not affect our analysis of behavioral parameters, 
although we did see the appearance of the low penetrance corpus 
callosum anomaly in a small number of animals.
In terms of its specific molecular lesion, the closest mutant to the 
one described here is a targeted phosphomimetic mutation (Tyr-
654Glu) (31). Murase et al. (8) provided fundamental evidence that 
the Tyr654 phosphorylation state is vital in coordinating activity-
induced presynaptic and postsynaptic plasticity. As the effects of 
the Bfc mutation appear to mimic that of Tyr654 phosphorylation, 
our synaptic morphological and functional results are consistent 
with the expected specific abnormalities at the synaptic junction 
and at the network level. There are also many phenotypic simi-
larities between Bfc and Tyr654Glu, including an anterior trunca-
tion and late embryonic lethality in homozygotes and a reduced 
interaction with cadherins. However, the Tyr654Glu mutation 
expresses a far stronger gain-of-function in WNT signaling, and 
this is particularly relevant when comparing adult heterozygous 
phenotypes, as unlike the Bfc/+ mice, Tyr654 heterozygotes have 
no documented craniofacial phenotype and show increased tumor 
initiation with intestinal adenomas.
Differences between the Bfc and Tyr654Glu mutants may be 
related to different capabilities of the 2 mutants to undergo nucle-
ar import and export, processes that are also particularly sensitive 
to the Tyr654 phosphorylation state (32). Similarly, amino acid 
substitutions in Arm12 can influence the ability of this repeat to 
interact with the C-terminal domain of β-catenin. Helix C can fold 
back on Arm12, blocking the binding of transcriptional coactiva-
tors to this area, while phosphorylation of Tyr654 prevents this 
fold back, leading to the subsequent phosphorylation of Ser675 
and the recruitment of transcriptional coactivators, including 
CBP and TBP (33). Y654E mutants do show an increased sensitiv-
ity to Ser675 phosphorylation; however, although we could not 
determine Ser675 phosphorylation state in Bfc/+ mice, we did not 
detect any change in the ability of the mutant protein to interact 
with the transcriptional coactivator CBP (data not shown). Such 
subtle differences in the functions of the 2 mutant proteins could 
underlie the discrete phenotypic consequences observed.
The deficits in cultured Bfc hippocampal neurons are consistent 
with studies overexpressing β-catenin. Expression of stabilized 
β-catenin increased dendritic growth and arborization, but this effect 
was inhibited by coexpression of the intracellular domain of N-cad-
herin that sequesters β-catenin (34). Moreover, the depolarizing 
effects of high K+ on dendritic arborization and neurite length were 
inhibited either by overexpression of the dominant-negative form of 
N-cadherin or by the presence of the Bfc allele. Critically, these effects 
have been shown to be independent of Wnt-related transcriptional 
changes, although Wnt-induced stabilization of β-catenin may be 
important in mediating depolarization-induced changes.
The cadherin/β-catenin complex has previously been demon-
strated to play a role in the recruitment and localization of SVs to 
synapses (8), and β-catenin is important for controlling the size and 
localization of the vesicle cluster. In fact, the deletion of β-catenin 
in hippocampal pyramidal neurons has been associated with a 
decrease in the density of vesicles of the reserve pool. We have shown 
that the overall functional connectivity of Bfc/+ is less strong with 
respect to WT dissociated networks. In particular, local connectivity 
among neurons seems to be mostly impaired, probably due to ineffi-
cient synapses, thus compromising the reliability of the signal trans-
mission. This loss in efficiency explains why Bfc/+ network activity is 
higher both for single spikes and bursting activity.
The conclusions of our study support a central role of β-catenin/
cadherins interactions in the molecular machinery that regulates 
synaptic plasticity and neuronal network connectivity. We envisage 
Figure 7
Morphological and functional deficits in Bfc/+ primary hippocampal 
neuronal cultures. (A) Representative images of primary cultures of +/+ 
and Bfc/+ hippocampal neurons after 8 days in culture. Scale bars are as 
indicated. Primary processes are shown in green, secondary processes 
in yellow. (B) Number of processes and neurite length are presented. 
Processes are significantly less in Bfc/+ neurons. *P = 0.02, 2-tailed 
t test. (C) Representative images of neuronal cultures transfected at 
1 DIV with β-catenin or control siRNA and fixed at 7 DIV. (D) siRNA against 
β-catenin efficiently decreased mRNA expression, as assessed by 
RT-qPCR (P < 0.01), while neurite extension was significantly reduced 
(*P < 0.05) in β-catenin–transfected neurons. (E) In vitro neuronal net-
work set-up showing (left to right) the high-density MEA chip, fluores-
cence image of the low density culture (β3-tubulin green, NeuN red) 
showing the sparse network distribution on a portion of the electrode 
array (black square), raw data traces of spiking activity acquired from 3 
different channels, raster plot of approximately 400 active channels (i.e., 
firing rate > 0.1 spike/s) showing synchronous firing and sustained burst-
ing activity. (F–I) cumulative distributions of network parameters (+/+ 
black, n = 4; Bfc/+ red, n = 6). Bold lines and shaded regions correspond 
to mean ± SEM. The Bfc/+ cultures were more excitable, as evidenced 
by the higher MFR (F) and MBR (G). Less evident is the variation for the 
MBD (H). The functional connectivity analysis based on cross-correlation 
shows that functional link length was also higher in Bfc/+ (I).
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Figure 8
Morphological and functional synaptic deficits in Bfc/+ adult hippocampus. (A) Representative electron microscope images from WT and 
heterozygous CA1 synapses; images show a section of a presynaptic axonal bouton (ax) containing the cluster of SVs and mitochondria (M) 
and the dendrite of a postsynaptic neuron (D); the postsynaptic density (PSD) is also visible (arrowhead). Scale bar: 200 nm. (B) Quantification 
of membrane-docked SV density (vesicles/μm) and PSD length (μm) was performed for 142 CA1 and 128 cortical +/+ (n = 3) and 152 CA1 and 
115 cortical Bfc/+ (n = 3) excitatory presynaptic terminals using ImageJ. (C) Experimental configuration used to perform electrophysiological 
recordings in adult hippocampal slices. (D) Slope of the fEPSP as a function of injected current recorded in hippocampal slices from WT (black 
squares, n = 7 mice, 10 slices) and Bfc/+ (white circles, n = 7 mice, 10 slices) animals. Representative traces are shown (inset). (E) Paired-pulse 
ratio as a function of the interstimulus interval for WT (n = 7 mice, 9 slices) and Bfc/+ (n = 7 mice, 9 slices) mice. Traces (inset) are normalized 
to the first stimulus fEPSP amplitude. (F and G) Slope of the fEPSP before and after tetanic (F) or θ-burst (G) stimulation in WT (black squares) 
and Bfc/+ (white circles) slices. Values are normalized to the fEPSP slope value under control conditions. (F) WT, n = 5 mice, 5 slices; Bfc/+, 
n = 5 mice, 6 slices. (G) WT, n = 4 mice, 5 slices; Bfc/+, n = 5 mice, 6 slices. Traces (inset) are normalized to the amplitude of the fEPSP under 
control conditions. **P < 0.01, ***P < 0.001.
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that our genetic model can result in a wealth of understanding in the 
molecular machinery that underlies β-catenin’s role in controlling 
synaptic changes and, ultimately, cognition. Furthermore, our abil-
ity to probe β-catenin function in this mouse model could also allow 
us to understand and perhaps treat a spectrum of human disorders 
associated with defective neurodevelopment including ID and ASD.
Methods
Patient recruitment
The present 4 individuals had been referred to the department of Human 
Genetics, Radboud University Medical Centre, for the evaluation of their 
moderate to severe ID. In all individuals, a clinical evaluation, followed by 
specific DNA diagnostic tests on indication and SNP array analysis, had 
been performed previously. These results were all normal. Subsequently, 2 
of the individuals (patients 2 and 4) were considered for family-based whole 
exome sequencing (WES) studies (trio-analysis). Results in patient 2 were 
recently reported by our group (trio 70, de Ligt et al.; ref. 13). Results in 
patient 4 were not previously reported. Patients 1 and 3 were included in a 
confirmation series of 765 persons with ID in which we used high-through-
put resequencing to screen new candidate genes, including CTNNB1, as 
described in the same publication by our group (3rd and 2nd patient with 
CTNNB1 mutation, Supplemental Figure 7 and de Ligt et al.; ref. 13).
Animals
Animals were genotyped using a TaqMan allelic discrimination assay under 
standard conditions. Primers used were as follows: 5′-TGGCCTCAAGGGC-
TAGTTTCT (forward) and 5′-TGAAAGCCGCTTCTTGTAATC (reverse). 
TaqMan MGB probes were as follows: FAM-TTTATTCCAGCAACATAC 
(WT) and VIC-TTTTATTCCAGCAAAATA (mutant). To maintain the fertil-
ity and fecundity of the Bfc mutant line, animals were bred by crossing het-
erozygotes on a congenic C57BL/6J background to C3H/HeH mice. Mutant 
F1 progeny were subsequently crossed to WT F1 animals to generate test 
cohorts. Unless otherwise stated, separate cohorts were used for all phenotyp-
ic analysis and as a source of all tissues in the current study. Following behav-
ioral tests, animals were sacrificed and any animals showing gross anatomi-
cal defects were excluded from the study. X-rays were determined using the 
pDEXA Sabre X-ray Bone Densitometer (Norland Medical Systems). Briefly, 
mice were anesthetized and placed in the apparatus; scanning was performed 
at a speed of 40 mm/s and a resolution of 1.0 × 1.0 mm/s (HAV: 0.020). 
Bone measurements were determined using associated software.
3D modeling of β-catenin and E-cadherin
The atomic coordinates of the crystal structure of the β-catenin/ 
E-cadherin complex (PDB 1I7X) (5) and the full-length crystal structure 
of β-catenin (PDB 2z6h) (2) were downloaded from the Protein Data Bank 
and visualized using PyMOL (PyMOL Molecular Graphics System, ver-
sion 1.3, Schrödinger LLC; http://www.pymol.org/ ). Using the IntFOLD2 
fold recognition method (35, 36), a full atomic 3D model was generated 
for the β-catenin sequence containing the point mutation Thr653Lys in 
the Arm12 domain. The phosphorylated tyrosine side chain (Tyr654-p) 
in the β-catenin WT structure was modeled using the Builder tool in 
PyMOL. The 2Z6H β-catenin crystal structure was superimposed with the 
original β-catenin chain in 1I7X to show the protein in full-length com-
plexed with the E-cadherin structure. Likewise, the IntFOLD2 model of 
β-catenin was superimposed with the original β-catenin crystal structure 
of WT β-catenin to show the Thr653Lys mutant residue. The side chain 
orientations that would depict the greatest steric clashes of Tyr654-p and 
Thr653Lys were chosen from all possible rotamers. For this, the Mutagen-
esis tool of PyMOL was utilized.
Cell transfection, protein immunoprecipitation, electrophoresis, and 
Western blotting
HEK293T cells were cotransfected with N-cadherin–EGFP (plasmid 
#18870; Addgene) and either WT–β-catenin–V5/His or Bfc–β-catenin–
V5/His (gifts from R. Arkell and A. D’Cruz, Australian National Univer-
sity, Acton, Australia) full-length cDNA constructs (1 μg of each) using 
jetPEI reagent (Source Bioscience); these were cultured for 48 hours. 
Cultured cell extracts (n = 3 per group) or whole hippocampus samples 
(n = 7 per genotype) were prepared by lysis in RIPA buffer as described 
previously (37). Immunoprecipitation (IP) of N-cadherin/β-catenin 
complexes from whole hippocampus extracts was performed using 
Dynabeads–Protein G Immunoprecipitation Kit (Invitrogen) according 
to the manufacturer’s instructions. For IP, 0.2 mg of lysate was used and 
30% of the eluted complex was loaded on polyacrylamide gels. As refer-
ence, 10 μg of total lysate was also loaded. Electrophoresis was performed 
using the Invitrogen system and then transferred to nitrocellulose mem-
brane using the iBlot (Life Technologies). Membranes were blocked for 
1 hour in blocking solution (5% skimmed milk in PBS + 0.1% Tween 20) 
and then incubated in primary antibody diluted in blocking solution 
overnight at 4°C. After extensive washing in PBS plus 0.1% Tween 20, 
membranes were incubated for 1 hour in the corresponding secondary 
antibody diluted in blocking solution and washed as before. For protein 
stability and IP studies, an antibody to the C-terminal end of β-catenin 
(ab16051; Abcam) and an antibody to N-cadherin (ab18203; Abcam) were 
used. Control IPs were carried out using normal rabbit IgG (sc-2027; 
Santa Cruz Biotechnology Inc.). Secondary antibodies used were goat-
anti-rabbit IgG-HRP (A6154; Sigma-Aldrich) and goat-anti-mouse IgG-
HRP (A4416; Sigma-Aldrich). For IP of transfected cells, lysates were 
incubated with anti-GFP monoclonal antibody (Roche) at 4°C over-
night, followed by protein G–sepharose (P3296; Sigma-Aldrich) at 4°C 
for 1 hour, after which beads were washed 3 times with RIPA buffer. 
Control IPs were carried out in the absence of transfected N-cadherin. 
Immunoprecipitated proteins were eluted from the beads by boiling in 
LDS buffer (Life Technologies) for 5 minutes. For quantitative 2-color 
Western blot analysis, blots were probed with both anti-GFP (Santa Cruz 
Biotechnology Inc.) and anti-V5 (Life Technologies) antibodies, washed, 
and incubated with IR fluorophore-conjugated secondary antibodies, 
IRDye 800 and IRDye 700, as described previously (37). Simultaneous 
2-color detection performed using an Odyssey infrared imaging system 
(LI-COR Biosciences). Quantitation of β-catenin–V5 in the immunopre-
cipitate was performed using Odyssey imager software, normalized to 
N-cadherin–EGFP fluorescence.
MRI
High-resolution T2-weighted and diffusion-weighted MR imaging of 
mouse brains was performed at 7 Tesla on paraformaldehyde-fixed speci-
mens using the following parameters: 3D fast spin-echo (TR = 550 ms, 
TE =33 ms, echo spacing 11 ms, voxel size of 0.094 mm3); diffusion weighted 
images (81 gradient orientations, b = 1225 s/mm2, ∂ = 5 ms, Δ = 10 ms, voxel 
size 131 × 131 × 500 μm, TR = 7500 ms, TEeff = 23 ms). Male Bfc/+ (n = 10) 
and control WT littermates (+/+; n = 9) were used. Volumes of anatomical 
labels were computed using a registration-based approach using 2 aver-
age reference templates, one for Bfc/+ and one for control subjects. Each 
template was manually labeled into anatomical regions and the volume of 
specific anatomical regions in individual subjects was obtained via a sym-
metric diffeomorphic registration algorithm (38). Diffusion-tensor Imag-
ing (DTI) tractrography was performed as follows: DWI images were first 
resampled to obtain isotropic voxels (129 μm3) and nonbrain tissue manu-
ally removed. Fractional anisotropy (FA) images were created by fitting 
a tensor model to the raw diffusion data using FMRIB software library, 
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Fear conditioning
Mice (n = 8 per group) were tested using a fear-conditioning protocol to 
test contextual memory. All mice were tested by means of the MultiCon-
ditioning System (TSE). The arena was 400 × 400 × 900 mm (w × d × h), 
and the house light was maintained at around 80 lux. After 120 seconds 
of habituation, mice were exposed for 28 seconds to the context serving as 
a conditioned stimulus, followed by an electric shock (2 s, 0.5 mA) repre-
senting the unconditioned stimulus for 3 trials separated by a 90-second 
interval. The memory test was performed 24 hours later, by reexposing the 
mice to the same context for 5 minutes, and 48 hours later, by reexposing 
the mice to the cue stimulus. Freezing was defined as a lack of movement 
besides respiration. The mean time of freezing behavior was expressed as a 
percentage of freezing in relation to the duration of test.
Timing learning
We subjected mice to a series of cognitive timing tests to asses both the 
capability of memorizing a reward event and to localize it in time. For 
the purpose of this experiment, we used classical and novel (home cage) 
operant systems (TSE Systems), which are based on the nose-poking 
activity of the animal.
Experiment 1: out-of-cage testing and peak procedure task. Bfc/+ (n = 12) and 
+/+ (n = 12) mice were subjected to a 1-hour training session in a classi-
cal operant chamber every day for 8 consecutive working days as previ-
ously described (40). A central-hole LED and a 60-dB background white 
noise signalled the beginning of each trial. When mice nose-poked the 
control station, the central-hole LED and the white noise were switched 
off and the target lateral hole, working as a feeding station, was illumi-
nated for 20 seconds (Figure 6A). After the first 10 seconds, a 20-mg food 
pellet reward was available at the feeding station mounted in the lateral 
hole. The ITI within the session was 40 to 50 seconds. In addition to the 
reward-based trials, a series of probe trials (in which no reward was deliv-
ered) was included. These occurred randomly during each session on an 
average of 1 out of 5 trials.
Experiment 2: home cage–automated testing and switch task. Six Bfc/+ and 6 +/+ 
mice were maintained in the home cage (equipped with a novel 3-hopper 
operant wall from TSE) to perform in the switch task as described previ-
ously (23). Briefly, all trials were self initiated by the animals by nose pok-
ing in 1 hopper (located in the middle of the operant wall) in the home 
cage. The rewards were delivered through the 2 lateral hoppers; 1 hopper 
was always associated with short light signals, while the other hopper was 
always associated with long light signals. The rewards were obtained only 
if the first nose poke of the animal occurred at the correct location follow-
ing the specific signal. We trained all mice to a steady-state performance; 
all analyses were performed keeping a 1:2 ratio between short- and long- 
signals (3 vs. 6 seconds, respectively). The test included 20% nonrewarded 
(probe) trials to independently test the timing uncertainty. Number of 
errors as well as switch latencies, time accuracy, and time precision describe 
timing cognitive endophenotypes in this test (as described in refs. 23, 24).
Primary neuronal cultures
Primary neuronal cultures were carried out both at IIT and the MRC. 
For the study of Bfc/+ and WT neurons, embryos obtained from dams 
on a hybrid C57BL/6J × C3H/HeH background at E14.5 were dissected 
to obtain the hippocampus. Tissue was collected in neurobasal medi-
um (Invitrogen) on ice, digested for 20 minutes with trypsin (0.25%) at 
37°C, and subsequently washed several times. Before plating, cells were 
resuspended by pipetting them gently up and down. Cells were allowed 
to grow in 24-well plates on glass coverslips coated with poly-D-lysine 
(Sigma-Aldrich) and laminin (Invitrogen) in neuronal growth medium, 
consisting of neurobasal medium containing 1% l-glutamine, 1% penicil-
v5.0 (FSL). Estimates of axonal fiber projections were computed using a 
deterministic fiber assignment by continuous tracking algorithm. Criteria 
for terminating the tracking of individual fibers included an anisotropy 
threshold (values below 0.15) and a maximum stiffness condition, so that 
the tracking was terminated when the diffusion directions in consecutive 
steps differed by more than 40°.
ASR and PPI
ASR and PPI were measured in Bfc/+ (n = 10) and +/+ (n = 10) mice 
using standard acoustic startle devices (Med Associates). For the startle 
response, the session consisted of a 5-minute acclimation period followed 
by five 110-db white noise pulses. Responses were expressed in arbitrary 
units and averaged. Duration of pulses were 10 ms and the inter-trial 
interval (ITI) was 25 seconds on average (20–30 seconds). For PPI, animals 
received a white noise pulse alone (110 db) preceded by a 60-db prepulse. 
The background noise was set at 45 dB. The interval between prepulse 
and pulse was 50 ms. Each trial was presented a total of 15 times with 
pseudorandom ITI. The test was conducted in dim light. The amount of 
PPI was measured in the prepulse plus startle trial types and expressed as 
percentage of the basal startle (19).
Rotarod
Bfc/+ (n = 10) and +/+ (n = 10) mice were challenged to keep their balance 
on a rotating rod. The latency period before falling off the rod was then 
measured and evaluated as a measure of their performance. After an initial 
training phase (2 minutes) in which all mice were familiarized with the test 
at a constant speed (4 rounds per minute [rpm]), the accelerating protocol 
was set from 4 rpm to 40 rpm. We submitted different cohorts of Bfc/+ 
(n = 10) and +/+ (n = 10) mice to 1 extensive session once a day for 3 days. 
Each session included 6 consecutive phases of 1 minute each. Three phases 
were accelerating phases from 4 to 40 rpm and 3 were stable phases at 4 rpm. 
The stable and the accelerating phases were alternated and all mice started 
the session with a stable phase.
Ultrasonic vocalization
Ultrasound vocalizations are emitted when a pup is isolated from the nest, 
its mother, and littermates (39). Six-day-old pups (n = 10 per genotype) 
were gently handled by the experimenter so as to remove 1 pup at a time 
from its cage and place it in an isolated cage where a microphone sensitive 
to ultrasonic sounds was set. The microphone was connected via an Avisoft 
UltraSoundGate 116 USB audio device to a personal computer. The moni-
toring occurred at room temperature, and the length of time of recording 
of ultrasounds was 5 minutes.
WM
In this test, Bfc/+ (n = 10) and +/+ (n = 10) mice were trained to locate a 
submerged or a visible platform within a tank of opaque water by using 
strategically placed visual cues. On the day prior to starting the experi-
ment, mice were placed on the platform for a 1-minute session to allow 
for orientation. Following this, on days 1 to 4, mice were placed in the 
water and were subjected to blocks of 4 trials with a 10- to 15-minute ITI. 
A visible platform was placed just above the water, and mice that found the 
platform within the allotted time remained there for 20 seconds. Mice that 
did not locate the platform within the allotted time were manually placed 
there. At the end of each day, the platform was removed and the mouse was 
placed in the tank for 1 minute (probe trial). From day 5 to 8, all mice were 
subjected to daily sessions as described above, but in this case, the platform 
was hidden just below the water. On day 9, the position of the platform was 
changed and the session was repeated. The locomotor activity of the mice 
was monitored by a video tracking system (Ethovision; Noldus).
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subsequently sliced coronally (350 μm) on a vibratome, and the regions 
of interest were cut into small pieces and post-fixed in 1% OsO4, 1.5% 
K4Fe(CN)6, and 0.1 M sodium cacodylate and en-bloc stained with 1% ura-
nyl acetate in 20% ethanol. Finally, samples were dehydrated and embedded 
in epoxy resin (Epon 812; TAAB). Ultrathin sections were stained with 1% 
uranyl acetate and Sato’s lead citrate and observed with a JEOL JEM-1011 
microscope operating at 100 kV. Images were acquired with an ORIUS 
SC1000 CCD camera (Gatan). Synaptic area, SV number, and active zone 
(AZ) length were quantified using ImageJ software. Statistical significance 
was determined using unpaired Student’s t test (GraphPad Prism 5.0).
LTP experiments
Adult (12-week-old) mice (n = 7 per genotype) were anesthetized with ure-
thane (Sigma-Aldrich) and decapitated. The brain was quickly removed 
and sliced with a vibratome (VT 1000M; Leica) in ice-cold cutting artifi-
cial CSF (ACSF), containing: 250 mM sucrose, 25 mM NaHCO3, 25 mM 
glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 1 mM CaCl2, and 1.5 mM MgSO4, 
pH 7.3, saturated with 95% O2 and 5% CO2. Coronal hippocampal slices 
(350 μm thickness) were recovered at room temperature for at least 2 hours 
before the beginning of the experiment in recording solution containing: 
125 mM NaCl, 25 mM NaHCO3, 25 mM glucose, 2.5 mM KCl, 1.25 mM 
NaH2PO4, 2 mM CaCl2, and 1.5 mM MgSO4, pH 7.3, saturated with 95% 
O2 and 5% CO2. Electrophysiological experiments were performed in a 
submerged chamber. fEPSPs were recorded in the stratum radiatum of 
the CA1 region with a glass micropipette (resistance 1–2 megaohms), 
which was filled with recording ACSF. Current stimulation pulses were 
applied to the Schaffer collaterals pathway via a concentric bipolar tung-
sten electrode (FHC) placed at least 300 microns away from the record-
ing electrode. Basal synaptic transmission was monitored at 0.067 Hz for 
at least 10 minutes (stimulation strength was set to 50% of the stimula-
tion value generating maximal fEPSP slope). LTP was induced by θ-burst 
stimulation (TBS, 4 TBSs with inter-TBS interval of 20 seconds; each TBS 
consisted of 4 bursts at 100 Hz delivered at 6 Hz; burst duration, 30 ms) 
or tetanic stimulation (100 Hz for 1 second). Data were acquired using the 
MultiClamp 700B amplifier and pClamp 10 software (Molecular Devices). 
Analysis of fEPSPs was performed with a Python custom program. The 
paired-pulse ratio was computed as the ratio between the fEPSP slope of 
the second stimulus and the fEPSP slope of the first stimulus. LTP was 
calculated in a 15-minute–long window, 45 minutes after the stimulus 
delivery. Statistical analysis was performed using GraphPad Prism. Two-
way ANOVA followed by Bonferroni’s post hoc test and Student’s t test 
were used to calculate statistical significance.
Statistics
For each experiment, data were analyzed with proper statistical tools. Two-
way ANOVA followed by post hoc comparisons was used. Data were also 
analyzed by unpaired Student’s t test (2 tailed; CI, 95%) using GraphPad 
Prism statistical software. Data are expressed as mean + SEM. All results 
are described throughout the text by reporting for each data set the rel-
evant statistics that were used. P < 0.05 was considered significant.
Study approval
All animal experiments were carried out in the United Kingdom under 
guidance issued by the Medical Research Council in Responsibility in the Use 
of Animals for Medical Research (July 1993) and Home Office project license 
no. 30/2198 and in Italy under project licence 106/2009 – B. All experi-
ments conformed to international guidelines on the ethical use of animals. 
For human studies, written informed consent was received from legal rep-
resentatives of all participants prior to inclusion. The study was approved 
by the local ethical committee (NL 13636.091.07).
lin/streptomycin, and 2% B-27 supplement, in a standard cell culture incu-
bator. DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlo-
rate; Invitrogen) was used to label the cultured neurons, and samples were 
subsequently embedded with ProLong (Invitrogen) mounting medium 
containing DAPI. Stained primary neurons were visualized using a LSM 
710 confocal microscope (Zeiss) with a ×63 objective (Plan-Apochromat 
63× NA 1.4). Measurements of dendrite (n = 6 per genotype) length and 
number for both Bfc/+ and siRNA cultures were analyzed using the associ-
ated software (ZEN 2010, release 6.0.0.320).
siRNA transfection and qPCR expression
For siRNA experiments, neurons were obtained from C57BL/6J embry-
os at E17.5. Cortical neurons at 1 day in culture (DIV) were transfected 
with Silencer Select Pre-designed siRNA against β-catenin (siRNA ID#: 
s63417) or control siRNA (both from Invitrogen) using Lipofectamine 
RNAiMAX Transfection Reagent (Invitrogen) according to the manufac-
turer’s protocol. Cells were analyzed for β-catenin expression or neurite 
extension at 7 DIVs. RNA extraction, reverse transcription, and quanti-
tative RT-PCR (RT-qPCR) were performed as previously described (41). 
Gene expression data were normalized by the multiple internal control 
gene method with GeNorm algorithm (42). β-Catenin (Ctnnb1) expression 
data were normalized to Ppia and Gapdh reference genes. Primer sequences 
were as follows: GAPDH (forward): 5′-GAACATCATCCCTGCATCCA-3′; 
GAPDH (reverse): 5′-CCAGTGAGCTTCCCGTTCA-3′; PPIA (forward): 
5′-CACTGTCGCTTTTCGCCGCTTG-3′; PPIA (reverse): 5′-TTTCTGCT-
GTCTTTGGAACTTTGTCTGC-3′; Ctnnb1 (forward): 5′-CAATGGCTTG-
GAATGAGACT-3′; Ctnnb1 (reverse): 5′-CCGTATCCACCAGAGTGAA-3′.
High-density MEA
The high-density MEA platform (3Brain GmbH) was described in previ-
ous papers (43, 44). Briefly, these MEAs are monolithic CMOS devices able 
to simultaneously record extracellular electrophysiological signals from 
4,096 electrodes at a sampling frequency of 7.7 kHz/electrode. Electrodes 
are squared (21 μm side) and are arranged in a 64 by 64 array (pitch 42 μm, 
580 electrode/mm2). These chips allow the characterization of network 
activity in sparse cultures with an unprecedented spatial and temporal 
resolution. Primary hippocampal neurons from mouse embryos were dis-
sociated at E14.5 and cultured on the APS MEAs. Chips were sterilized 
for 20 minutes in ethanol 80% and coated with a layer of poly-ethyl-imide 
(PEI). Each embryo was dissected separately, and 50 μl of cell suspension 
was dropped on the recording area of each chip (about 200 cells/μl). After 
cellular adhesion, chip reservoirs were filled with 1.5 ml of Neurobasal 
(Invitrogen) and were maintained in an incubator until recordings. After 
14 days in vitro, network activity was recorded for 10 minutes, both in 
basal conditions and after adding 30 μM of BIC.
For the analysis (n = 4, +/+; n = 6, Bfc/+), we used the precise timing spike 
detection (PTSD) algorithm for spike detection (45) and custom Python 
scripts. All further analyses on the spike trains were computed by custom 
scripts in Python. In particular, bursting activity was detected with a sin-
gle channel spike train burst detector (46) and network-wide activity was 
characterized by MFR, MBR, and MBD, computed only on active channels 
(i.e., firing rate > 0.1 Hz). Functional connectivity analysis was performed 
by crosscorrelating spike events among electrodes, and the strongest (i.e., 
most correlated) 100 to 200 links were considered.
Electron microscopy
Bfc/+ (n = 3) and +/+ (n = 3) mice were anesthetized deeply with 20% ure-
thane (0.1 ml/10 g) and perfused transcardially with ice-cold physiological 
saline for 3 to 4 minutes followed by a 0.1 M sodium cacodylate buffer con-
taining 2% paraformaldehyde and 2% glutaraldehyde (pH 7.4). Brains were 
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